Two-wire technique for installing hammertoe implant

Information

  • Patent Grant
  • 9474561
  • Patent Number
    9,474,561
  • Date Filed
    Tuesday, November 19, 2013
    11 years ago
  • Date Issued
    Tuesday, October 25, 2016
    8 years ago
Abstract
A method includes inserting a first surgical device into an exposed first end of a first bone until a trailing end of the first surgical device is disposed adjacent to the first end of the first bone. A second surgical device is inserted into an exposed first end of a second bone while the first surgical device remains disposed within the first bone. A first portion of an implant is advanced into the second bone while being engaged with a passageway defined by the implant such that the implant is guided by the second surgical device. The second surgical device is removed from the second bone and from its engagement with the implant. The first bone is repositioned such that the first surgical device is aligned with the passageway defined by the implant, and the first bone is forced into engagement with a second portion of the implant.
Description
FIELD OF DISCLOSURE

The disclosed system and method relate implants. More specifically, the disclosed system and method relate to installing an implant for treating hammer toe.


BACKGROUND

Hammer toe is a deformity of the toe that affects the alignment of the bones adjacent to the proximal interphalangeal (PIP) joint. Hammer toe can cause pain and can lead to difficulty in walking or wearing shoes. A hammer toe can often result in an open sore or wound on the foot. In some instances, surgery can be required to correct the deformity by fusing one or both of the PIP and distal interphalangeal (DIP) joints.


The most common corrective surgery includes the placement of a pin or rod in the distal, middle, and proximal phalangees of the foot to fuse the PIP and DIP joints. The pin or rod is cut at the tip of the toe, externally of the body. A plastic or polymeric ball is placed over the exposed end of the rod, which remains in the foot of the patient until the PIP and/or DIP joints are fused in approximately 6 to 12 weeks. This conventional treatment has several drawbacks such as preventing the patient from wearing closed toe shoes while the rod or pin is in place, and the plastic or polymeric ball can snag a bed sheet or other object due to it extending from the tip of the toe resulting in substantial pain for the patient.


Another conventional implant includes a pair of threaded members that are disposed within adjacent bones of a patient's foot. The implants are then coupled to one another through male-female connection mechanism, which is difficult to install in situ and has a tendency to separate.


Yet another conventional implant has body including an oval head and a pair of feet, which are initially compressed. The implant is formed from nitinol and is refrigerated until it is ready to be installed. The head and feet of the implant expand due to the rising temperature of the implant to provide an outward force on the surrounding bone when installed. However, the temperature sensitive material can result in the implant deploying or expanding prior to being installed, which requires a new implant to be used.


Accordingly, an improved implant for treating hammer toe is desirable.


SUMMARY

In some embodiments, a method includes inserting a first surgical device into an exposed first end of a first bone until a trailing end of the first surgical device is disposed adjacent to the first end of the first bone. A second surgical device is inserted into an exposed first end of a second bone while the first surgical device remains disposed within the first bone. A first portion of an implant is advanced into the second bone while being engaged with a passageway defined by the implant such that the implant is guided by the second surgical device. The second surgical device is removed from the second bone and from its engagement with the implant. The first bone is repositioned such that the first surgical device is aligned with the passageway defined by the implant, and the first bone is forced into engagement with a second portion of the implant.


In some embodiments, a method includes forming an incision to gain access to a joint between first and second bones, flexing the first and second bones such that the first and second bones are disposed at an angle with respect to one another, inserting a first surgical device into the first bone until a first end of the first surgical device is disposed adjacent to a first end of the first bone, and inserting a second surgical device into the second bone while the first surgical device remains disposed within the first bone. A first portion of an implant is advanced into the second bone while a passageway defined by the implant is engaged with the second surgical device such that the implant is guided by the second surgical device. The second surgical device is removed from the second bone and from its engagement with the implant. The first bone is repositioned such that the first surgical device is aligned with the passageway defined by the defined by the implant, and the first bone is forced into engagement with a second portion of the implant.


In some embodiments, a surgical method includes gaining access to a joint between a middle phalange and a proximal phalange, inserting a first end of a first surgical device into a proximal end of the middle phalange, advancing the first surgical device into the middle phalange and a distal phalange until a second end of the first surgical device is disposed adjacent to the proximal end of the middle phalange, and inserting a first end of a second surgical device into a distal end of the proximal phalange while the first surgical device remains disposed within the middle and distal phalanges. A first portion of an implant is advanced into the proximal phalange using the second surgical device as a guide. The second implant is removed. The first surgical device is inserted into a passageway defined by the implant while the first surgical device remains disposed within the middle and distal phalange, and the first surgical device is removed from its engagement with the implant, middle phalange, and distal phalange.





BRIEF DESCRIPTION OF THE DRAWINGS

These and other features and advantages of the present invention will be more fully disclosed in, or rendered obvious by the following detailed description of the preferred embodiments of the invention, which are to be considered together with the accompanying drawings wherein like numbers refer to like parts and further wherein:



FIG. 1 is an isometric view of an improved hammer toe implant according to some embodiments;



FIG. 2 is a top side view of the hammer toe implant illustrated in FIG. 1;



FIG. 3 is a top side view of the blade portion of the hammer toe implant illustrated in FIG. 6;



FIG. 4 is a sectional view of the hammer toe implant taken along line 3-3 in FIG. 2;



FIG. 5 is an end on view of the hammer toe implant taken along line 4-4 in FIG. 2;



FIG. 6 is an isometric view of an improved, cannulated hammer toe implant according to some embodiments;



FIG. 7 is a side view of one example of a driving adapter for use with the hammer toe implants illustrated in FIGS. 1 and 6;



FIG. 8 is an end view of the driving adapter illustrated in FIG. 7;



FIG. 9 is a side view of another example of a driving adapter for use with the hammer toe implants illustrated in FIGS. 1 and 6;



FIG. 10 is an end view of the driving adapter illustrated in FIG. 9;



FIG. 11A is an assembly view of a hammer toe implant engaged by a driving adapter;



FIG. 11B is an assembly view of a cannulated hammer toe implant engaged by a cannulated driving adapter;



FIG. 12A illustrates the middle and proximal phalangees of a foot being resected;



FIG. 12B illustrates the middle and proximal phalangees of a foot being resected;



FIG. 13 illustrates a hammer toe implant being driven into a proximal phalange;



FIG. 14 illustrates a middle phalange being drilled or broached;



FIG. 15 illustrates a blade of a hammer toe implant extending from the proximal phalange with the middle phalange having been drilled or broached;



FIG. 16 illustrates a hammer toe implant installed in the middle and proximal phalangees;



FIG. 17 illustrates another example of a driving assembly for installing an implant;



FIG. 18 illustrates a side view of the driving assembly illustrated in FIG. 17;



FIG. 19 is an isometric view of an adapter of the driving assembly illustrated in FIG. 17;



FIG. 20 is an end view of the adapter illustrated in FIG. 19;



FIG. 21 is a cross-sectional view of the adapter taken along line 21-21 in FIG. 20;



FIG. 22 is a cross-sectional view of the adapter taken along line 22-22 in FIG. 20;



FIG. 23 is a plan view of the driving rod of the driving assembly illustrated in FIG. 17;



FIG. 24 is a cross-sectional view of the driving rod taken along line 24-24 in FIG. 23;



FIG. 25 is a cross-sectional view of the fin of the driving rod taken along line 25-25 in FIG. 23;



FIG. 26 is a plan view of driving assembly illustrated in FIG. 17 without the o-ring;



FIG. 27 is a cross-sectional view of the handle taken along line 27-27 in FIG. 26;



FIG. 28A illustrates an implant coupled to the adapter of the driving assembly illustrated in FIG. 17;



FIG. 28B illustrates an implant coupled to the adapter of the driving assembly illustrated in FIG. 17;



FIG. 29 illustrates a hammer toe implant being driven into a proximal phalange;



FIG. 30 illustrates an implant kit comprising a hammer toe implant preloaded in the adapter shown in FIGS. 19-22;



FIG. 31A is an isometric view of an implant kit according to some embodiments whose adapter has an implant receiving end configured to couple to an implant by an O-ring according to the adapter of FIGS. 19, 28A and 28B and having a driver shaft coupling end configured for coupling to the driver shaft by mating male and female threads;



FIG. 31B is an isometric view of an implant kit according to some embodiments whose adapter has an implant receiving end configured to couple to an implant by an O-ring according to the adapter of FIGS. 19, 28A and 28B and having a driver shaft coupling end configured for coupling to the driver shaft by a pair of opposing tabs;



FIG. 31C is a cross-sectional view of an adapter having a driver shaft coupling end illustrated in FIG. 31B and an implant receiving end according to some embodiments;



FIG. 31D is a cross-sectional view of an adapter having a driver shaft coupling end illustrated in FIG. 31A according to some embodiments;



FIG. 32A is an isometric view of an implant kit according to some embodiments whose adapter has an implant receiving end configured to couple to an implant by an O-ring according to the adapter of FIGS. 19, 28A and 28B and having a driver shaft coupling end configured for coupling to the driver shaft by an O-ring;



FIG. 32B is a side view of an adapter has an implant receiving end configured to couple to an implant by an O-ring according to the adapter of FIGS. 19, 28A and 28B and having a driver shaft coupling end configured for coupling to the driver shaft by an O-ring according to some embodiments;



FIG. 32C is a cross-sectional view of an implant kit whose adapter has a driver shaft coupling end for coupling to the driver shaft by an O-ring according to some embodiments;



FIG. 33A is a side view of an implant kit according to some embodiments whose adapter has an implant receiving end configured to couple to an implant by an O-ring according to the adapter of FIGS. 19, 28A and 28B and having a driver shaft coupling end configured for coupling to the driver shaft by an off-set clip;



FIG. 33B is an end perspective view of an adapter having a driver shaft coupling end configured for coupling to the driver shaft by an off-set clip according to some embodiments;



FIG. 33C is a cross-sectional view of an adapter having a driver shaft coupling end configured for coupling to the driver shaft by an off-set clip according to some embodiments;



FIG. 34A is an end perspective view of an adapter having a driver shaft coupling end configured for coupling to the driver shaft by a C-clip according to some embodiments;



FIG. 34B is an end view of an adapter having a driver shaft coupling end configured for coupling to the driver shaft by a C-clip according to some embodiments;



FIG. 34C is an end view of an adapter having a driver shaft coupling end configured for coupling to the driver shaft by a C-clip according to some embodiments;



FIG. 34D is cross-sectional view of an implant kit according to some embodiments having a driver shaft coupling end configured for coupling to the driver shaft by a C-clip;



FIG. 34E is a side view of a driver shaft configured for coupling to a driver shaft-coupling end of the adapter illustrated in FIG. 34D according to some embodiments;



FIG. 35A is an isometric view of some embodiments of an implant kit comprising an adapter that is configured for coupling to an hammer toe implant using a collet;



FIG. 35B is an isometric view of some embodiments of an implant kit comprising an adapter that is configured for coupling to an hammer toe implant using a collet and showing a hammer toe implant received in the adapter;



FIG. 35C is an isometric view of some embodiments of an implant kit comprising an adapter that is configured for coupling to an hammer toe implant using a collet;



FIG. 35D is a an end view of the implant kit illustrated in FIG. 35B;



FIG. 35E is cross-sectional view of the implant kit taken along line 25-25 in FIG. 35D;



FIG. 35F is cross-sectional view of the implant kit taken along line 25-25 in FIG. 35D;



FIG. 36A is an isometric view of another example of hammer toe implant according to some embodiments;



FIG. 36B is a top side view of the hammer toe implant illustrated in FIG. 36A;



FIG. 37 is a flow diagram of one example of method of installing an implant in accordance with some embodiments;



FIG. 38 illustrates a joint being accessed using a cutting tool in accordance with some embodiments;



FIG. 39 illustrates the middle and proximal phalangees of a foot being resected in accordance with some embodiments;



FIG. 40 illustrates a surgical device being inserted through the middle and distal phalanges in accordance with some embodiments;



FIG. 41 illustrates a second surgical device being inserted to a proximal phalange while the first surgical device remains disposed within the middle and distal phalanges in accordance with some embodiments;



FIG. 42A illustrates an implant and surgical device being disposed within the proximal phalange while the first surgical device remains disposed within the middle and distal phalanges in accordance with some embodiments;



FIG. 42B illustrates the implant being disposed within the proximal phalange after the second surgical device has been removed and while the first surgical device remains disposed within the middle and distal phalanges in accordance with some embodiments;



FIG. 43 illustrates the middle phalange having been pressed into engagement with the implant using the first surgical device as a guide in accordance with some embodiments;



FIG. 44 illustrates the first surgical device being advanced into the proximal phalange and metatarsal in accordance with some embodiments;



FIG. 45 illustrates one example of an end of the first surgical device having a blunted end while disposed within the middle, proximal, and distal phalanges and within the implant in accordance with some embodiments; and



FIG. 46 illustrates a hammer toe implant installed in the middle and proximal phalanges in accordance with some embodiments.





DETAILED DESCRIPTION

This description of preferred embodiments is intended to be read in connection with the accompanying drawings, which are to be considered part of the entire written description. The drawing figures are not necessarily to scale and certain features of the invention can be shown exaggerated in scale or in somewhat schematic form in the interest of clarity and conciseness. In the description, relative terms such as “horizontal,” “vertical,” “up,” “down,” “top,” and “bottom” as well as derivatives thereof (e.g., “horizontally,” “downwardly,” “upwardly,” etc.) should be construed to refer to the orientation as then described or as shown in the drawing figure under discussion. These relative terms are for convenience of description and normally are not intended to require a particular orientation. Terms including “inwardly” versus “outwardly,” “longitudinal” versus “lateral,” and the like are to be interpreted relative to one another or relative to an axis of elongation, or an axis or center of rotation, as appropriate. Terms concerning attachments, coupling, and the like, such as “connected” and “interconnected,” refer to a relationship wherein structures are secured or attached to one another either directly or indirectly through intervening structures, as well as both movable or rigid attachments or relationships, unless expressly described otherwise. The term “operatively connected” is such an attachment, coupling or connection that allows the pertinent structures to operate as intended by virtue of that relationship.



FIG. 1 illustrates one example of an improved implant 100 for treating hammer toe. As shown in FIG. 1, implant 100 includes a threaded portion 102 and a blade portion 104, which are connected together at an engagement portion 106. In some embodiments, implant 100 has a substantially linear geometry. In some embodiments, implant 100 has an overall length of approximately 19 mm (approximately 0.75 inches) (e.g. 18.9-19.1 mm (0.74-0.76 inches)). In some embodiments, blade portion 104 can be disposed at angle with respect to a longitudinal axis defined by the threaded portion 102. The angle can be between zero and 45 degrees, and more particularly between approximately five and fifteen degrees, although one skilled in the art will understand that implant 100 can have other dimensions and be provided in different sizes. For example, implant 100 can be provided in lengths of 16 mm and 22 mm, to name a few potential lengths.


In some embodiments, threaded portion 102 includes a plurality of threads 108 disposed along its entire length, which can be approximately 13 mm (approximately 0.5 inches) (e.g. 12.9-13.1 mm (0.49-0.51 inches)) although one skilled in the art will understand that threaded portion 102 can have other dimensions and be provided in different sizes. For example, threaded portion 102 can be provided in lengths of 10 mm and 15 mm, to name a few potential lengths. The tip 110 of threaded portion 102 can be pointed to facilitate the advancement of threads 108 into bone. Threads 108 can have a maximum outer diameter of approximately 2 mm (approximately 0.08 inches), although one skilled in the art will understand that thread portion 102 can have other dimensions and be configured to be received within a phalange bone of a person. For example, threads can have an outer diameter of approximately 2.4 mm and 1.6 mm, to name a few potential possibilities.


As shown in FIGS. 1-4 and 6, blade portion 104 can have a substantially cylindrical cross-sectional geometry. One skilled in the art will understand that blade portion 104 can have other cross-sectional geometries. In some embodiments, blade portion 104 can have a taper defined by a plurality of blades 112. For example, as best shown in FIGS. 2 and 3, the taper of blade portion 104 can be at an angle relative to the longitudinal axis defined by the elongated central portion of implant 100. In some embodiments, the taper is at an angle (θT) between 1 and 10 degrees relative to the longitudinal axis defined by the elongated central portion of implant 100. For example, the taper can be at an angle (θT) of approximately 5 degrees (e.g. 4.9-5.1 degrees) degrees relative to the longitudinal axis defined by the elongated central portion of implant 100. In some embodiments, blade portion 104 includes a taper along its diameter defined by the plurality of blades 112. In the illustrated embodiments of FIGS. 2, 3 and 5, the plurality of blades 112 include a first blade 112 having a first diameter disposed proximate the engagement portion 106 and a second blade 112 having a second diameter smaller than the first diameter disposed proximate a terminating end 118 of the blade portion 104. In some embodiments, the first diameter can be approximately 5 mm (approximately 0.20 inches) (e.g. 4.9-5.1 mm) (0.19-0.21 inches) and the second diameter can be approximately 4.5 mm (approximately 0.18 inches) (e.g. 4.4-4.6 mm) although one skilled in the art will understand that the plurality of blades 112 can have other diameters and other dimensions. For example, the first diameter can be provided as in lengths of 4 mm and 6 mm, to name a few potential diameters. The inventors have found that the tapered blade portion 104 permits each successive blade 112 of blade portion 104 to achieve interference with bone during insertion which enhances fixation of the blade portion 104 compared to a non-tapered blade portion 104. In the illustrated embodiment, the blades 112 of blade portion 104 include a valley 126 between blades 112 and the teeth portions 114 of each blade 112. In some embodiments, valley 126 of teeth portions 114 of each blade 112 is substantially the same. In other embodiments, the valleys 126 of teeth portions 114 vary as the respective diameters of the successive blades are tapered.


In some embodiments, the terminating end 118 of blade portion 104 is a point, although one skilled in the art will understand that blade portion 104 can have a terminating end of other dimensions, sizes and/or shapes. In the illustrated embodiment of FIGS. 3 and 6, the terminating end 118 of blade portion 104 is cannulated. In various embodiments (FIGS. 3 and 6), the blade portion 104 and threaded portion 102 of implant 100 are cannulated. In some embodiments, implant 100 (FIGS. 3, 6, 11B) includes a groove 109 sized and configured to receive a k-wire, pin, or other surgical device or instrument that extends along the length of implant 100 in a direction that is parallel to a longitudinal length defined by implant 100. In some embodiments, the taper of blade portion 104 can be defined by the plurality of blades 112 having successively smaller diameters between a blade 112 disposed proximate engagement portion 106 and a blade 112 disposed proximate terminating end 118 of the blade portion 104.


In various embodiments, each blade 112 of the plurality of blades 112 of blade portion 104 include a plurality of grooved portions 116 and a plurality of teeth portions 114 to form a substantially cruciform cross-sectional geometry (FIG. 5). In the illustrated embodiment of FIG. 5, each blade 112 of blade portion 104 having a substantially cylindrical cross-section includes a plurality of substantially rounded grooved portions 116 formed along an axis parallel to a longitudinal axis of blade portion 104 and a plurality of teeth portions 114. As shown in FIGS. 1-5 and 6, blade portion 104 can have a substantially cylindrical cross-sectional geometry including a plurality of blades 112 having respective substantially cruciform cross-sectional geometries defined by a grooved portion 116 being disposed in each quadrant (112a-d) of each blade 112. In some embodiments, each blade 112 of blade portion 104 includes a pair of opposing grooved portions 116 (e.g. in quadrants 112b and 112d and in quadrants 112a and 112c respectively) to form a substantially cruciform cross-sectional geometry. As shown in FIG. 5, the grooved portions 116 of each pair of opposing grooved portions 116 (e.g. in quadrants 112a and 112c and 112b and 112d respectively) are substantially symmetrical. In the illustrated embodiment of FIG. 5, the grooved portions 116 disposed in each quadrant (112a-d) of each blade 112 are substantially symmetrical and the teeth portions 114 of each blade 112 are substantially symmetrical.


As shown more clearly in the illustrated embodiments of FIGS. 1, 3, 5 and 6, each blade 112 of blade portion 104 includes no flat surfaces. In some embodiments, a centerline of grooved portion 116 of each blade 112 of blade portion 104 is dimensioned such that it is tangent to respective diameters measured at the intersections of grooved portion 116 and the respective teeth portions 114. In the illustrated embodiments, grooved portions 116 are concave in shape and teeth portions 114 are convex in shape. In the illustrated embodiments, the respective surfaces of each blade 112 are rounded. In some embodiments, teeth portions 114 are serrated.


In some embodiments, engagement portion 106 can include a pair of protrusions extending from opposite sides of implant 100 and having rounded outer edges. In some embodiments, for example as shown in FIG. 2, the sides of the protrusions of engagement portion 106 can be substantially parallel with each other. In some embodiments, at least a portion of the implant 100 is cannulated (FIGS. 3, 6). The inventors have found that a cannulated implant 100 design can permit surgeons to stabilize joints (e.g. a metatarsal phalangeal joint (MPJ)) during a surgical procedure.


Implant 100 is configured to be installed using a driving adapter 200 such as the one illustrated in FIGS. 7-10. The driving adapter 200 has an elongated body 202 having a proximal end 204 and a distal end 206. Body 202 of driving adapter 200 can have a circular cross-sectional geometry, although one skilled in the art will understand that body 202 can have other cross-sectional geometries including, but not limited to, triangular, rectangular, pentagonal, and hexagonal to name a few.


Proximal end 204 can be substantially solid and have a rounded tip 208. In some embodiments, proximal end 204 and distal end 206 can be cannulated such as, for example, to receive a k-wire. Distal end 206 can define a slot 210 sized and configured to receive blade portion 104 of implant 100 therein. In some embodiments, slot 210 can have a cylindrical cross-sectional geometry and have a depth that is sufficient to receive the entire blade portion 104 of implant 100 such that distal edges 212 of slot 210 contact the protrusions of engagement portion 106. In some embodiments, slot 210 can have a cylindrical, cruciform cross-sectional geometry and have a depth that is sufficient to receive the entire blade portion 104 of implant 100 such that distal edges 212 of slot 210 contact the protrusions of engagement portion 106. However, one skilled in the art will understand that slot 210 can have other cross-sectional geometries and dimensions. Slot 210 can extend through side walls 214 of body 202 as shown in FIGS. 7 and 8, or side walls 214 can completely enclose slot 210 as shown in FIGS. 9 and 10.


If the driving adapter 200 is to be used with an implant 100 having a substantially linear lengthwise geometry such as the implant 100 illustrated in FIGS. 1-6, then slot 210 can extend in a direction that is substantially parallel to an axis defined by body 202 of driving adapter 200. If driving adapter 200 is to be used with an implant 100 having a blade portion 104 that extends at an angle with respect to an axis defined by elongated threaded portion 102, then slot 210 can extend from distal edges 212 at an angle with respect to an axis defined by the length of body 202 such that elongated threaded portion 102 of implant 100 is linearly aligned with body 202 of driving adapter 200 as shown in FIGS. 11A and 11B. For example, if blade portion 104 of implant 100 extends at a ten degree angle with respect to an axis defined by elongated threaded portion 102, then slot 210 of driving adapter 200 can extend at a ten degree angle with respect to a longitudinal axis defined by body 202 such that threaded portion 102 of implant 100 and body 202 of driving adapter 200 are substantially linearly aligned.


A method of installing implant 100 in the proximal interphalangeal joint (PIP) 300 is described with reference to FIGS. 12A-16. However, one skilled in the art will understand that the technique for installing the implant 100 can be applied to other joints such as, for example, the distal interphelangeal (DIP) joint between middle phalange 304 and distal phalange 306. As shown in FIGS. 12A and 12B, an incision is made to open the PIP joint 300 and a cutting tool 400 having a blade 402 can be used to resect adjacent faces of proximal phalange 302 and middle phalange 304. The resected surfaces of proximal phalange 302 and middle phalange 304 can be debrided as understood by one skilled in the art.


Blade portion 104 of implant 100 can be disposed within slot 210 of driving adapter 200 as shown in FIGS. 11A and 11B. In some embodiments, the body 202 of driving adapter 200 can be cannulated. In some embodiments, a k-wire, pin or other suitable surgical device can be inserted into the middle phalange 304 and driven through distal phalange and out of the end of the toe (not shown). A k-wire can be inserted such that a trailing end is disposed within middle phalange 304 or otherwise positioned with respect to the joint such that cannulated implant 100 can be driven into proximal phalange 302. In various embodiments, the body 202 of driving adapter 200 can be secured in a chuck 412 of a drill 410 or other driving instrument as shown in FIG. 13. Drill 410 or other driving instrument is used to drive the threaded portion 102 of implant 100 into the resected surface of proximal phalange 302. With the threaded portion 102 of implant 100 disposed within proximal phalange 302, driving adapter 200 can be disengaged from blade portion 104 of implant 100.


Middle phalange 304 can be predrilled or broached using drill 410 to create a hole 308 as shown in FIGS. 14 and 15. The predrilled or broached middle phalange 304 is then repositioned such that the predrilled hole or broach 308 aligns with the blade portion 104 of implant 100. In some embodiments, a dimension (e.g. diameter or width) of the predrilled hole or broach 308 is less than a dimension of blade portion 104 to permit a first blade 112 to achieve interference with the bone and enhance fixation of blade 104. For example, in some embodiments, “valley-to-valley” dimension of blade portion 104 (e.g. the diametrical dimension of blade portion 104 between blades 112). In some embodiments, a k-wire or other suitable surgical device is disposed within middle phalange 304 can be aligned with groove 109 of cannulated implant 100 (FIGS. 3, 6, 11B) disposed within proximal phalange 302. In various embodiments, the middle phalange 304 can be then pressed into engagement with the blade portion 104 as shown in FIG. 16. Serrated teeth portions or edges 114 of blade portion 104 help to maintain the engagement between middle phalange 304 and blade portion 104 of implant 100. In various embodiments, a k-wire or other suitable surgical device can be advanced into the joint, into and through middle phalange 302, into the respective metatarsal and through cannulated implant 100. In various embodiments, the k-wire or other suitable surgical device can remain within the patient for a period of time, e.g. minutes, hours, days or months, and can then be removed to leave behind cannulated implant 100.



FIGS. 17-27 illustrate some embodiments of a driver assembly 500 for installing an implant into bone. As shown in FIGS. 17 and 18, driver assembly 500 includes an adapter 502 coupled to a driving rod 516 onto which a handle 534 is over-molded or otherwise coupled. Adapter 502 includes a body 504 with a substantially rectangular side profile comprising side walls 506-1, 506-2, 506-3, and 506-4 (collectively referred to as “side walls 506”) and a pair of end walls 508-1, 508-2 (collectively referred to as “end walls 508”) having a substantially square geometry as best seen in FIGS. 19-22.


Body 504 defines a recess 510 along the length of side walls 506. Recess 510 is dimensioned such that an o-ring 544 (FIGS. 17 and 18) can be received therein. Additionally, recess 510 is located along side walls 506 at a distance from end walls 508 such that recess 510 is aligned with a valley 126 of teeth portions 114 along the circumference of blade portion 104.


End wall 508-1 defines an aperture 512 (FIG. 20) having a geometry that complements the cross-sectional geometry of blade portion 104 of implant 100. For example, if implant 100 has a cylindrical, cruciform straight blade portion 104 as illustrated in FIG. 2, then aperture 512 can extend approximately parallel to the lengthwise direction of side walls 506 (FIGS. 21-22). If the blade portion 104 of implant 100 is angled (not shown), then aperture 512 can extend from wall 508-1 at an angle relative to the plane defined by side wall 506-2 or 506-4 as will be understood by one skilled in the art. In some embodiments, aperture 512 has a depth that is greater than or equal to a length of blade portion 104 such that blade portion 104 can be received within body 504 and engagement portion 106 abuts end wall 508-1. Similarly, end wall 508-2 defines an aperture that is sized and configured to receive an end of elongated driving rod 516 therein.


As best seen in FIGS. 23-25, driving rod 516 includes a fin 518 disposed at a first end 520. Fin 518 disposed at end 520 of driving rod 516 has a rectangular shape and is sized and configured to be received within aperture 512 of adapter 502. Fin 518 defines a slot 522, which is sized and configured to receive a pin (not shown) for cross-pinning driving rod 516 to adapter 502. In some embodiments, end 520 can have other cross-sectional geometries including, but not limited to, triangular, square, and pentagonal, to name a few possibilities, that are configured to be received within aperture 514. Adapter 502 can be over-molded onto the end of driving rod 516. However, one skilled in the art will understand that adapter 502 can be cross-pinned or otherwise coupled to driving rod 516.


The opposite end 524 of driving rod 516 defines a pair of flats 526, 528, which are disposed on opposite sides of driving rod 516. As best seen in FIG. 23, flat 526 extends from tip 530 and is linearly spaced from flat 528, which is disposed at a greater distance from tip 530 than flat 526. However, one skilled in the art will understand that flats 526, 528 can be disposed at other positions along driving rod 516. Flats 526, 528 are configured to provide a contact surface for coupling to handle 532 (FIG. 26), which can be over-molded onto driving rod 516, such that rotation of handle 532 is translated to driving rod 516.


Turning now to FIGS. 26 and 27, handle 532 has an elongated body 534 that includes a plurality of ribs 536 that extend in a longitudinal direction along body 534 to provide a gripping surface for a user. As best seen in FIGS. 17 and 22, a smooth surface 538 interrupts circumferential ridges 540, which are disposed adjacent to proximal end 542 also for providing a gripping surface for a user.


Driver assembly 500 can be provided in a kit with a first adapter 502 for use with a straight implant 100 and a second adapter for use with an angled implant 100. A plurality of implants 100 of different sizes can also be provided in the kit. The kit can be used in an operation similar to the operation described above with respect to FIGS. 12A-16.


Blade portion 104 of implant 100 is disposed within aperture 512 of adapter 502 as shown in FIGS. 28A and 28B. With blade portion 104 disposed within aperture 512, an o-ring 544 (FIGS. 17 and 18) is placed in recess 510 defined by adapter 502 and within a valley 126 of serrated edges 112 along the top and bottom sides 114, 116 of blade portion 104. O-ring 544 secures implant 100 to adapter 502 such that implant does not move axially out of aperture 512.


Once implant 100 is secured to adapter 502, the surgeon uses handle 534 to manually drive threaded portion 102 of implant 100 into the resected surface of proximal phalange 302 as illustrated in FIG. 29. Implant 100 is driven into proximal phalange 302 until engagement portion 106 abuts proximal phalange 302. Implant 100 is decoupled from adapter 502 by axially pulling handle 534 away from implant 100 with sufficient force to flex o-ring 544 and separate adapter 502 from implant 100.


Middle phalange 304 can be predrilled or broached using drill 410 to create a hole 308 as shown in FIGS. 14 and 15. The predrilled or broached middle phalange 304 is then repositioned such that the predrilled hole or broach 308 aligns with the blade portion 104 of implant 100. The middle phalange 304 is then pressed into engagement with the blade portion 104 as shown in FIG. 16. Serrated teeth portions 114 of blade portion 104 help to maintain the engagement between middle phalange 304 and blade portion 104 of implant 100.


The implant described above can advantageously be installed through a small incision as described above. Additionally, the improved implant is completely disposed within a toe of a patient, which prevents the implant from being caught on bed sheets or other objects like the conventional pins.


According to an aspect of the present disclosure, the implant can be preloaded into an adapter and provided as an implant kit. Various embodiments of such an implant kit will be described below.



FIG. 30 is a view of the implant kit 1000 in which the implant 100, 100A is preloaded into the adapter 502. FIG. 30 is viewed from within the plane of FIGS. 28A and 28B so that the view shows the full circumference of the blade portion 104, 104A. In this view of FIG. 30, with the blade portion 104, 104A fully inserted into the adapter 502, 502A, an elastic O-ring 544 (also shown in FIGS. 17 and 18) placed in the groove 510 retains the implant 100, 100A in the adapter 502, 502A by preventing the implant from sliding out of the adapter. The cross-sections of the O-ring is shown in FIG. 30. The groove 510 is cut into the adapter with a sufficient depth so that when the O-ring 544 is placed therein the O-ring is positioned within the valley 126 between two adjacent teeth portions 114 about the circumference of the blade portion 104, 104A, as shown in FIG. 30. Because the O-ring 544 is elastic, one can push the blade portion 104, 104A of the implant into the adapter with sufficient force for one or more of the teeth portions 114 to push past the O-ring 544 when assembling the implant kit 1000. Once the implant kit 1000 is assembled, however, the O-ring 544 secures and retains the implant 100, 100A in the adapter 502 until one intentionally pulls off the adapter 502 after the implant is driven into a bone.


In use, the surgeon would attach the implant kit 1000 to the driver tool 500 to manually drive the threaded portion 102 of the implant 100, 100A into the resected surface of proximal phalange 302 as illustrated in FIG. 29. The implant 100, 100A is driven into the proximal phalange 302 until engagement portion 106 abuts the proximal phalange 302. The implant 100, 100A is then decoupled from the adapter 502 by axially pulling the adapter 502 away from the implant 100, 100A with sufficient force to push the O-ring 544 outward and separate the adapter 502 from the implant 100, 100A. Referring to FIGS. 31A through 35F, various embodiments for removably coupling the implant kits disclosed above to a driver shaft 516 of a driver tool 500 will be described. FIGS. 31A-31D are various views of some embodiments of an adapter such as the adapter 502 of FIGS. 28A, 28B, and 30 having a driver shaft coupling end configured for coupling to the adapter-engaging end 517a, 517b of the driver shaft. The driver shaft coupling end of the adapter 502 is provided with the longitudinally extending bore 514, configured for receiving the adapter-engaging end 517a, 517b, and a pair of opposing tabs 541, 542 extending longitudinally in the direction away from the implant engaging end. FIG. 31A shows a driver shaft 516 whose adapter-engaging end 517a is configured with screw threads. In this embodiment, the driver-engaging end of the adapter 502 is configured to threadably couple to the adapter-engaging end 517a of the driver shaft 502 and the tabs 541, 542 provide additional locking mechanism. FIG. 31B shows a driver shaft 516 whose adapter-engaging end 517b is configured with a magnetic tip. In this embodiment, the driver-engaging end of the adapter 502 is configured to magnetically couple to the adapter-engaging end 517b and the tabs 541, 542 provide additional locking mechanism. The adapter 502 would then be provided with a magnet or a piece of magnetic material 503 for magnetically coupling to the adapter-engaging end 517b.



FIGS. 31C and 31D are cross-sectional views of the adapter 502 showing the driver-engaging end. FIG. 31C shows the profile of the tabs 541 and 542 and the bore 514 for receiving the adapter-engaging end 517 of the driver shaft. If the adapter 502 is intended for use with the driver shaft 516 of the embodiment shown in FIG. 31A, the bore 514 is tapped with screw thread for threadably engaging the threaded adapter-engaging end 517a. If the adapter 502 is intended for use with the driver shaft 516 of the embodiment shown in FIG. 31B, the bore 514 is provided with a magnet 530 for engaging the magnetized tip of the adapter-engaging end 517b.


The tabs 541, 542 and the adapter-engaging end 517a, 517b are configured for further mechanical coupling. In the illustrated example, the tabs 541, 542 are provided with bumps 550 and the adapter-engaging end 517a, 517b of the driver shaft is provided with corresponding cutouts 560 for mating with the bumps 550.


Shown in FIGS. 32A-32C are various views of an implant kit 1040 comprising an adapter 1502 and an implant 100 according to some embodiments. The implant 100 is removably coupled to the adapter 1502 at the adapter's implant-receiving end 1503 by a first O-ring 544 in the same manner as with the adapter 502 shown in FIGS. 19, 28A, 28B and 30. The adapter 1502 has a circumferential groove 1510, in which the first O-ring 544 is provided, in the outer surface of the adapter in proximity to the implant-receiving end 1503. As with the adapter embodiment 502, the adapter 1502 comprises a slot provided in the implant-receiving end 1503 that receives the blade portion 104 of the implant 100. The adapter 1502 also has a driver shaft coupling end 1504 configured for removably coupling to the driver shaft 516 by a second O-ring 546. The driver shaft coupling end 1504 is provided with a longitudinally extending bore 1514 for receiving the adapter-engaging end 1517 of the driver shaft 516. The driver shaft coupling end 1504 is also provided with a second circumferential groove 1512 in which the second O-ring 546 is disposed. The adapter-engaging end 1517 has a cross-section that is larger than the inner diameter of the second O-ring 546 but has a turned down section 1518 that has a reduced cross-section for accommodating the second O-ring 546 when the adapter-engaging end 1517 is inserted into the bore 1514 as shown in FIG. 32C. When the adapter-engaging end 1517 is inserted into the bore 1514, the turned down section 1518 and the second circumferential groove 1512 align so that the second O-ring 546 rests in the turned down section 1518. The second O-ring 546 thus provides an interference with the adapter-engaging end 1517 to prevent the adapter 1502 and the driver shaft 516 from decoupling without exerting some force.



FIGS. 33A-33C are various views of an adapter 2502 that can be used in an implant kit 1050 according to some embodiments of the present disclosure. The adapter 2502 has an implant receiving end 2503 configured to couple to an implant 100 by an O-ring 544 according to the adapter of FIGS. 19, 28A and 28B and a driver shaft coupling end 2504 configured for coupling to the driver shaft 516 by an off-set clip 2515. The driver shaft coupling end 2504 has a longitudinally extending bore 2514 for receiving an adapter-engaging end 2517 of the driver shaft 516. The off-set clip 2515 is cantilevered to the adapter having a cantilever portion 2515a connected to the adapter body and a locking portion 2515b extending orthogonal to the cantilever portion 2515a. The locking portion 2515b is provided with a through hole 2516 for the adapter-engaging end 2517 of the driver shaft 516. The through hole 2516 and the bore 2514 are off-set to enable the locking function. The adapter-engaging end 2517 is provided with a groove or a cutout 2518 on one side for removably engaging the off-set clip 2515. To insert the adapter-engaging end 2517 into the adapter, the user pushes the off-set clip 2515 in the direction shown by the arrow P in FIG. 33C, which is a longitudinal cross-sectional view of the adapter 2502. That will deflect the cantilever portion 2515a in the direction P and bring the through hole 2516 in linear alignment with the bore 2514 so that the adapter-engaging end 2517 can be inserted through the through hole 2516 and the bore 2514. Once the adapter-engaging end 2517 is fully inserted, the off-set clip 2515 is released to its normal off-set position as shown in FIG. 40C. The off-set position of the locking portion 2515b keeps the locking portion 2515b seated within the cutout 2518 keeping the driver shaft 516 coupled to the adapter 2502. The off-set clip can be configured so that in the configuration shown in FIG. 33C, the locking portion 2515b maintains a force against the cutout 2518 in the direction opposite the arrow P. To remove the adapter 2502 from the adapter-engaging end 2517, the off-set clip 2515 is pushed in the direction of the arrow P shown in FIG. 33C bringing the through hole 2516 and the bore 2514 into longitudinal alignment and thus removing the interference between the locking portion 2515b and the cutout 2518. In some embodiments, the adapter-engaging end 2517 may simply be straight without the cutout 2518 structure. In that embodiment, the urging of the locking portion 2515b against the straight adapter-engaging end 2517 in the direction opposite the arrow P will provide sufficient frictional interference to keep the driver shaft 516 and the adapter 2502 coupled.



FIGS. 34A-34E are various views of the driver shaft coupling end 3504 of an adapter 3502 that is configured for removably coupling to the implant 100 to form an implant kit according to some embodiments. The implant-receiving end of the adapter 3502 is configured to couple to the implant by an O-ring 544 according to the adapter of FIGS. 19, 28A and 28B. The driver shaft coupling end 3504 is configured to removably couple to the adapter-engaging end 3517 of the driver shaft 516 by a C-clip 3550. The C-clip 3550 is generally shaped like a letter C and has two prongs 3550a and 3550b joined at one end and open at the opposite end. The driver shaft coupling end 3504 of the adapter 3502 is provided with a bore 3514 for receiving the adapter-engaging end 3517. The driver shaft coupling end 3504 is further configured with a pair of slots 3512 for receiving the C-clip 3550 and oriented orthogonal to the longitudinal axis of the adapter 3502. FIG. 34B is an end view of the adapter assembly viewed from the driver shaft coupling end 3504 showing the C-clip 3550 clipped on to the adapter 3502 by sliding the two prongs 3550a, 3550b into the pair of slots 3512. The pair of slots 3512 are cut into the adapter 3502 sufficiently deep to overlap with the bore 3514 so that when the C-clip 3550 is clipped on to the adapter 3502, interference tabs 3551 on each of the two prongs 3550a, 3550b protrude into the bore 3514 as shown in FIG. 34B. When the adapter-engaging end 3517 of the driver shaft 516 is inserted into the bore 3514 and locked with the C-clip 3550 as shown in the longitudinal cross-sectional view of FIG. 34E, the interference tabs 3551 reside in the corresponding slots 3518 provided in the adapter-engaging end 3517 and prevent the adapter 3502 and the driver shaft 516 from decoupling. In this embodiment, the interference tabs 3551 are oriented substantially parallel to one another. In one preferred embodiment, the interference tabs 3551 can be oriented in a slant so that the interference tabs 3551 are tapered towards the open end of the C-clip 3550. The tapered interference tabs 3551 makes is easier to insert the C-clip 3550 over the adapter-engaging end 3517.



FIGS. 35A-35F are various views of some embodiments of an implant kit 1030 comprising an adapter 2600 configured for coupling to a hammer toe implant 100 using a thread-biased collet 2650. The adapter 2600 comprises a sleeve 2602 and the collet 2650. The sleeve 2602 has openings at each end and a bore 2615 longitudinally extending between the two openings. As shown in FIGS. 35A and 35B, sleeve 2602 can include a plurality of ribs that extend in a longitudinal direction along sleeve 2602 to provide a gripping surface for a user. The collet 2650 is received in the bore 2615. The sleeve 2602 has a first end 2605 that forms one of the openings.


Referring to FIG. 35A, the collet 2650 is generally cylindrical in shape and comprises an implant receiving portion 2657 and a threaded portion 2660. The threaded portion 2660 is provided with screw threads 2663. The implant receiving portion 2657 has an implant-receiving opening 2612 for receiving the blade portion 104 of the implant 100. The implant-receiving opening 2612 is defined by collet segments 2651 which are defined by slots 2652 extending from the implant-receiving end towards the threaded portion 2660. This example of a collet has two collet segments 2651. The implant receiving portion 2657 is flared in its outer circumference so that the diameter of the receiving portion 2657 increases towards the implant-receiving end of the collet. FIG. 35B shows the collet 2650 with the implant 100 received in the slots 2652. FIG. 35C shows the collet with an indicated direction of rotation L to drive the sleeve 2602 onto the threaded portion 2660 to retain the implant 100 within implant receiving portion 2657. In various embodiments, the refraction and extension of the collet 2650 is enabled by turning the sleeve 2602 about a longitudinal axis relative to the collet 2650 thus engaging the screw threads 2607 and 2663. In some embodiments, sleeve 2602 is driven by hand in direction of rotation L to retain implant 100 within implant receiving portion 2657 pre-implantation and in an opposite direction of L to release implant 100 post-implantation.



FIG. 35D is an end view of the adapter 2600 illustrated in FIGS. 35A-35C and shows the implant 100 received in the implant receiving end 2657 and slots 2652. The implant-receiving opening 2612 of implant receiving portion 2657 has a geometry that complements the cross-sectional geometry of blade portion 104 of implant 100 and is defined by collet segments 2651 which are defined by slots 2652. For example, if implant 100 has a cylindrical, cruciform straight blade portion 104 as illustrated in FIG. 2 and FIG. 35A, then implant-receiving opening 2612 can extend approximately parallel to the lengthwise direction of collet 2650. If the blade portion 104 of implant 100 is angled (not shown), then implant-receiving opening 2612 can extend from end 2603 at an angle relative to the plane defined by collet 2650 as will be understood by one skilled in the art. In various embodiments, as shown in FIGS. 35A and 35D, collet segments 2651 of implant receiving end 2657 include radii features to complement radii features of the cylindrical, cruciform blade portion 104.


Referring now to FIGS. 35E and 35F, the bore 2615 has a screw threaded portion 2607 and a main portion 2605. The threaded portion 2607 is configured to threadably engage the threads 2663 of the collet 2650. The main portion 2605 has a sufficiently large diameter to accommodate a substantial portion of the implant receiving portion 2657 of the collet 2650 without imposing any mechanical interference. The main portion 2605 terminates at the first end 2603 where the opening formed therein has a diameter smaller than the maximum diameter of the flared implant receiving portion 2657. This configuration allows the collet segments 2651 to be constricted by the first end 2603 when the collet 2650 is retracted into the sleeve 2602 in the direction R shown in FIG. 35F and close in on the blade portion 104 of the implant 100, thus, retaining the implant. Conversely, the implant 100 can be released from the adapter 2600 by extending the collet 2650 outward from the sleeve 2602 in the direction E shown in FIG. 35F. In some embodiments, and as shown in FIG. 35F, sleeve 2602 includes an internal taper to interface with an external taper of the implant receiving portion 2657 of collet 2650.



FIGS. 36A and 36B illustrate one example of an implant 100A that can be used with the two-wire insertion technique described herein. Implant 100A is identified to implant 100 except that implant 100A includes a central passageway 101 that extends through the entire length of implant 100A. Descriptions of the features of implant 100A that are identical to the features of implant 100 are not repeated.



FIG. 37 is a flow diagram of one example of installing a hammer toe implant using a two-wire technique in accordance with some embodiments. Method 2000 depicted in FIG. 37 is described with reference to FIGS. 38-45, which illustrate various steps of installing a hammer toe implant. Although the following descriptions are provided with respect to installing implant 100A, it will be appreciated that implants having other shapes and configurations can be used so long as they include a passageway for accommodating a k-wire as will be apparent after reading the following description. One example of such an alternative implant is disclosed in commonly assigned U.S. patent application Ser. No. 14/043,105, filed Oct. 1, 2013 and entitled “Hammer Toe Implant and Method,” the entirety of which is incorporated by reference herein. As will be appreciated by one of ordinary skill in the art, the implants can have other fixation features. For example, both ends of the implant can have blades instead of one blade portion and one threaded portion. In some embodiments, the implant can include a blade or threaded portion at one end and an expanding portion (e.g., divergent legs or arms) at the opposite end.


Further, although method 2000 is described as installing an implant in the bones of a proximal interphelangeal joint (PIP) 300, i.e., the joint between proximal phalange 302 and middle phalange 304, one of ordinary skill in the art will understand that the technique may be applied to other joints, such as, for example, the distal interphelangeal (DIP) joint, i.e., joint 308 between middle phalange 304 and distal phalange 306.


At block 2002 of FIG. 37, an incision is made to expose the PIP joint 300. For example, FIG. 38 illustrates one example of the PIP joint 300 being exposed by using a cutting tool 400 having a blade 402.


At optional block 2004 (FIG. 37), the blade 402 of a cutting tool 400, such as a saw, is used to resect one or both of the adjacent faces of proximal phalange 302 and middle phalange 304 as illustrated in FIG. 39 The resected surfaces of proximal phalange 302 and middle phalange 304 can be debrided as understood by one skilled in the art.


At block 2006 (FIG. 37), bones are flexed apart and a first k-wire, pin, or other surgical device 10-1 is inserted into the proximal face of middle phalange 304. In some embodiments, the leading end 10A-1 of wire 10-1 is forced across the joint between middle phalange 304 and distal phalange 306, through distal phalange 306, and out the distal tip 306A of distal phalange 306 as shown in FIG. 40. The k-wire 10-1 continues to be advanced until the trailing end 10B-1 is disposed adjacent to the proximal face 304A of middle phalange 304 such that joint 300 is accessible. For example, the trailing end 10B-1 of wire 10-1 can extend slight from or be flush with the proximal face 304A of middle phalange 304. In some embodiments, trailing end 10B-1 is disposed entirely within middle phalange 304.


At block 2008 (FIG. 37), a second k-wire or pin 10-2 in inserted into the exposed distal face 302A of proximal phalange 302 while the first wire 10-1 is still disposed within middle phalange 304 and distal phalange 306 as shown in FIG. 41. In some embodiments, leading end 10A-2 of wire 10-2 is advanced such that it is disposed within proximal phalange 302. However, in some embodiments, leading end 10A-2 is further advanced such that it is received within metatarsal 310 and/or cuneiform (not shown).


At block 2010 (FIG. 37), implant 100A is driven into engagement with proximal phalange 302 as shown in FIG. 42A. In some embodiments, the implant 100A is driven into proximal phalange 302 using wire 10-2 as a guide. For example, the implant 100A is slid over trailing end 10B-2 of wire 10-2 by receiving wire 10-2 within passageway 101 of implant 100A. An installation tool, such as one of driver assembly 500 and/or installation kit 1030, including adapter 2600, can be used to engage the blade portion 104 of implant 100A and drive threaded portion 102 into middle phalange 302 as implant 100A is guided by wire 10-2.


At block 2012 (FIG. 37), second k-wire or pin 10-2 is removed from its engagement with implant 100A and proximal phalange 302 (and metatarsal 310 and cuneiform (not shown), if applicable). Implant 100A remains engaged with proximal phalange 302 once wire 10-2 has been removed as shown in FIG. 42B.


At block 2014 (FIG. 37), the middle phalange 304 is moved into engagement with implant 100A. For example, with wire 10-1 still disposed within middle and distal phalanges 304, 306, the middle and distal phalanges 304, 306 and wire 10-1 are manipulated such that the trailing end 10B-1 of wire 10-1 is aligned with the passageway 101 of implant 100A. In some embodiments, wire 10-1 can be inserted into passageway 101 prior to the middle phalange 304 being forced into engagement with the blade portion 104 of implant 100A as shown in FIG. 43.


At optional block 2016 (FIG. 37), end 10B-1 of k-wire 10-1 is advanced through proximal phalange 302, and into metatarsal 310 (and/or cuneiform (not shown)) as shown in FIG. 44.


At optional block 2018 (FIG. 37), what was initially leading end 10A-1 (FIGS. 40, 41, 42A, and 42B), is blunted or capped to provide an exposed blunt end 10C-1 as shown in FIG. 45.


At block 2020, after the surgical device 10-1 remains within a patient for a period of time, e.g., minutes, hours, days, or months, the surgical device 10-1 is removed to leave behind implant 100A as shown in FIG. 46.


Although the invention has been described in terms of exemplary embodiments, it is not limited thereto. Rather, the appended claims should be construed broadly, to include other variants and embodiments of the invention, which may be made by those skilled in the art without departing from the scope and range of equivalents of the invention.


Some embodiments provide an implant including an elongated threaded portion and a blade portion extending from the elongated threaded portion. The blade portion has a substantially cylindrical cross-sectional geometry and a taper defined by a plurality of blades.


Some embodiments provide an implant including an elongated threaded portion and a blade portion extending from the elongated threaded portion. The blade portion includes a plurality of blades having respective substantially cruciform cross-sectional geometries defined by a grooved portion being disposed in each quadrant of each blade.


Some embodiments provide a method including forming an incision to gain access to a joint between first and second bones, flexing the first and second bones such that the bones are disposed at an angle from one another, and advancing a threaded portion of an implant into the first bone. The implant includes a blade portion extending from an elongated threaded portion. The blade portion has a substantially cylindrical cross-sectional geometry and a taper defined by a plurality of blades. The method also includes repositioning the second bone such that a middle of the second bone is approximately aligned with the blade portion of the implant and forcing the second bone into engagement with the blade portion of the implant.


Although the invention has been described in terms of exemplary embodiments, it is not limited thereto. Rather, the appended claims should be construed broadly, to include other variants and embodiments of the invention, which can be made by those skilled in the art without departing from the scope and range of equivalents of the invention.

Claims
  • 1. A method, comprising: inserting a first surgical device into an exposed first end of a first bone until a trailing end of the first surgical device is disposed adjacent to the first end of the first bone;inserting a second surgical device into an exposed first end of a second bone while the first surgical device remains disposed within the first bone;advancing a first portion of an implant into the second bone while being engaged with a passageway defined by the implant such that the implant is guided by the second surgical device;removing the second surgical device from the second bone and from its engagement with the implant;repositioning the first bone such that the first surgical device is aligned with the passageway defined by the implant; andforcing the first bone into engagement with a second portion of the implant.
  • 2. The method of claim 1, further comprising forming an incision to gain access to a joint between the first bone and the second bone;flexing the first bone relative to the second bone to expose the first end of the first bone and the first end of the second bone; andresecting at least one of the first end of the first bone and the first and of the second bone.
  • 3. The method of claim 1, further comprising removing the first surgical device from the first bone and its engagement with the implant.
  • 4. The method of claim 1, wherein the passageway is a central passageway that extends through the entirety of the implant.
  • 5. The method of claim 1, wherein the first portion of the implant is a threaded portion and the second portion of the implant is a blade portion.
  • 6. A method, comprising: forming an incision to gain access to a joint between first and second bones;flexing the first and second bones such that the first and second bones are disposed at an angle with respect to one another;inserting a first surgical device into the first bone until a first end of the first surgical device is disposed adjacent to a first end of the first bone;inserting a second surgical device into the second bone while the first surgical device remains disposed within the first bone;advancing a first portion of an implant into the second bone while a passageway defined by the implant is engaged with the second surgical device such that the implant is guided by the second surgical device;removing the second surgical device from the second bone and from its engagement with the implant;repositioning the first bone such that the first surgical device is aligned with the passageway defined by the implant; andforcing the first bone into engagement with a second portion of the implant.
  • 7. The method of claim 6, further comprising removing the first surgical device from the first bone and its engagement with the implant.
  • 8. The method of claim 6, further comprising resecting an end of each the first and second bones prior to inserting the first and second surgical devices.
  • 9. The method of claim 6, wherein the first bone is a middle phalange of a foot, and the second bone is a proximal phalange of the foot.
  • 10. The method of claim 9, wherein the first portion of the implant is a threaded portion and the second portion of the implant is a blade portion.
  • 11. A surgical method, comprising: gaining access to a joint between a middle phalange and a proximal phalange;inserting a first end of a first surgical device into a proximal end of the middle phalange;advancing the first surgical device into the middle phalange and a distal phalange until a second end of the first surgical device is disposed adjacent to the proximal end of the middle phalange;inserting a first end of a second surgical device into a distal end of the proximal phalange while the first surgical device remains disposed within the middle and distal phalanges;advancing a first portion of an implant into the proximal phalange using the second surgical device as a guide;removing the second surgical device;inserting the first surgical device into a passageway defined by the implant while the first surgical device remains disposed within the middle and distal phalange; andremoving the first surgical device from its engagement with the implant, middle phalange, and distal phalange.
  • 12. The surgical method of claim 11, further comprising: advancing a second end of the first surgical device through the proximal phalange and into at least one of a metatarsal and a cuneiform; andblunting the first end of the first surgical device.
  • 13. The surgical method of claim 12, further comprising, after a period of time, removing the first surgical device while the implant remains engaged with the proximal phalange and the middle phalange.
  • 14. The surgical method of claim 11, further comprising resecting an end of each the middle phalange and the proximal phalange prior to inserting the first and second surgical devices.
  • 15. The surgical method of claim 11, wherein the passageway is a central passageway that extends through the entirety of the implant.
  • 16. The surgical method of claim 11, wherein the first portion of the implant is a threaded portion and the second portion of the implant is a blade portion.
US Referenced Citations (492)
Number Name Date Kind
321389 Schirmer Jun 1885 A
346148 Durham Jul 1886 A
348589 Sloan Sep 1886 A
373074 Jones Nov 1887 A
430236 Rogers Jun 1890 A
561968 Coulon Jun 1896 A
736121 Lipscomb Aug 1903 A
821025 Davies May 1906 A
882937 Pegley Mar 1908 A
1966835 Stites Jul 1934 A
2140749 Kaplan Dec 1938 A
2361107 Johnson Oct 1944 A
2451747 Kindt Oct 1948 A
2490364 Livingston Dec 1949 A
2600517 Rushing Jun 1952 A
2697370 Brooks Dec 1954 A
2832245 Burrows Apr 1958 A
2895368 Place Jul 1959 A
3462765 Swanson Aug 1969 A
3466669 Flatt Sep 1969 A
3593342 Niebauer et al. Jul 1971 A
3681786 Lynch Aug 1972 A
3739403 Nicolle Jun 1973 A
3759257 Fischer et al. Sep 1973 A
3760802 Fischer et al. Sep 1973 A
3779239 Fischer et al. Dec 1973 A
3824631 Burstein et al. Jul 1974 A
D243716 Treace et al. Mar 1977 S
4047524 Hall Sep 1977 A
4096896 Engel Jun 1978 A
4156296 Johnson et al. May 1979 A
4170990 Baumgart et al. Oct 1979 A
4175555 Herbert Nov 1979 A
4198713 Swanson Apr 1980 A
4204284 Koeneman May 1980 A
4213208 Marne Jul 1980 A
4237875 Termanini Dec 1980 A
4262665 Roalstad et al. Apr 1981 A
4263903 Griggs Apr 1981 A
4275717 Bolesky Jun 1981 A
4276660 Laure Jul 1981 A
4278091 Borzone Jul 1981 A
4304011 Whelan, III Dec 1981 A
4321002 Froehlich Mar 1982 A
4364382 Mennen Dec 1982 A
4367562 Gauthier Jan 1983 A
4404874 Lieser Sep 1983 A
4434796 Karapetian et al. Mar 1984 A
4454875 Pratt et al. Jun 1984 A
4485816 Krumme Dec 1984 A
D277509 Lawrence et al. Feb 1985 S
D277784 Sgariato et al. Feb 1985 S
4516569 Evans et al. May 1985 A
4570623 Ellison et al. Feb 1986 A
4590928 Hunt et al. May 1986 A
D284099 Laporta et al. Jun 1986 S
4634382 Kusano et al. Jan 1987 A
4642122 Steffee Feb 1987 A
4655661 Brandt Apr 1987 A
D291731 Alkins Sep 1987 S
4723540 Gilmer, Jr. Feb 1988 A
4723541 Reese Feb 1988 A
4731087 Sculco et al. Mar 1988 A
4756711 Mai et al. Jul 1988 A
4759768 Hermann et al. Jul 1988 A
4790304 Rosenberg Dec 1988 A
4865606 Rehder Sep 1989 A
4908031 Frisch Mar 1990 A
4915092 Firica et al. Apr 1990 A
4932974 Pappas et al. Jun 1990 A
4940467 Tronzo Jul 1990 A
4955916 Carignan et al. Sep 1990 A
4963144 Huene Oct 1990 A
4969909 Barouk Nov 1990 A
5002563 Pyka et al. Mar 1991 A
5007932 Bekki et al. Apr 1991 A
5011497 Persson Apr 1991 A
5019079 Ross May 1991 A
5029753 Hipon et al. Jul 1991 A
5037440 Koenig Aug 1991 A
5046513 Gatturna et al. Sep 1991 A
5047059 Saffar Sep 1991 A
5053038 Sheehan Oct 1991 A
5059193 Kuslich Oct 1991 A
5062851 Branemark Nov 1991 A
5089009 Green Feb 1992 A
5092896 Meuli et al. Mar 1992 A
5108395 Laurain Apr 1992 A
5133761 Krouskop Jul 1992 A
5147363 Harle Sep 1992 A
5171252 Friedland Dec 1992 A
5179915 Cohen et al. Jan 1993 A
5190546 Jervis Mar 1993 A
5199839 DeHaitre Apr 1993 A
5207712 Cohen May 1993 A
5209756 Seedhom et al. May 1993 A
5213347 Rulon et al. May 1993 A
5222975 Crainich Jun 1993 A
5246443 Mai Sep 1993 A
5281225 Vicenzi Jan 1994 A
5304204 Bregen Apr 1994 A
5324307 Jarrett et al. Jun 1994 A
5326364 Clift, Jr. et al. Jul 1994 A
5326366 Pascarella et al. Jul 1994 A
5330476 Hiot et al. Jul 1994 A
5342396 Cook Aug 1994 A
5352229 Goble et al. Oct 1994 A
5354301 Castellano Oct 1994 A
5358405 Imai Oct 1994 A
5360450 Giannini Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5380334 Torrie et al. Jan 1995 A
5395372 Holt et al. Mar 1995 A
5405400 Linscheid et al. Apr 1995 A
5405401 Lippincott, III et al. Apr 1995 A
5417692 Goble et al. May 1995 A
5425776 Cohen Jun 1995 A
5425777 Sarkisian et al. Jun 1995 A
5437674 Worcel et al. Aug 1995 A
5449359 Groiso Sep 1995 A
5454814 Comte Oct 1995 A
5458648 Berman et al. Oct 1995 A
5470230 Daftary et al. Nov 1995 A
5474557 Mai Dec 1995 A
5480447 Skiba Jan 1996 A
5484443 Pascarella et al. Jan 1996 A
5498265 Asnis et al. Mar 1996 A
5507822 Bouchon et al. Apr 1996 A
5516248 DeHaitre May 1996 A
5522903 Sokolow et al. Jun 1996 A
5529075 Clark Jun 1996 A
5536127 Pennig Jul 1996 A
5549681 Segmüller et al. Aug 1996 A
5551871 Besselink et al. Sep 1996 A
5554157 Errico et al. Sep 1996 A
5578034 Estes Nov 1996 A
5591165 Jackson Jan 1997 A
5595563 Moisdon Jan 1997 A
5601558 Torrie et al. Feb 1997 A
D378409 Michelson Mar 1997 S
5634925 Urbanski Jun 1997 A
5643264 Sherman et al. Jul 1997 A
5645599 Samani Jul 1997 A
5660188 Groiso Aug 1997 A
5669913 Zobel Sep 1997 A
5674297 Lane et al. Oct 1997 A
5683466 Vitale Nov 1997 A
5690629 Asher et al. Nov 1997 A
5702472 Huebner Dec 1997 A
5707395 Li Jan 1998 A
5713903 Sander et al. Feb 1998 A
5713904 Errico et al. Feb 1998 A
5720753 Sander et al. Feb 1998 A
5725585 Zobel Mar 1998 A
5728127 Asher et al. Mar 1998 A
5733307 Dinsdale Mar 1998 A
5741256 Bresina Apr 1998 A
5749916 Richelsoph May 1998 A
5769852 Brångnemark Jun 1998 A
5776202 Copf et al. Jul 1998 A
5779707 Berthelet et al. Jul 1998 A
5782927 Klawitter et al. Jul 1998 A
5785713 Jobe Jul 1998 A
5840078 Yerys Nov 1998 A
5853414 Groiso Dec 1998 A
5876434 Flomenblit et al. Mar 1999 A
5882444 Flomenblit et al. Mar 1999 A
5893850 Cachia Apr 1999 A
5919193 Slavitt Jul 1999 A
5928236 Augagneur et al. Jul 1999 A
5941890 Voegele et al. Aug 1999 A
5951288 Sawa Sep 1999 A
5958159 Prandi Sep 1999 A
5980524 Justin et al. Nov 1999 A
5984970 Bramlet Nov 1999 A
5984971 Faccioli et al. Nov 1999 A
6011497 Tsang et al. Jan 2000 A
6017366 Berman Jan 2000 A
6030162 Huebner Feb 2000 A
6045573 Wenstrom et al. Apr 2000 A
6048151 Kwee Apr 2000 A
6048343 Mathis et al. Apr 2000 A
6083242 Cook Jul 2000 A
6099571 Knapp Aug 2000 A
6102642 Kawashita et al. Aug 2000 A
6146387 Trott et al. Nov 2000 A
6187009 Herzog et al. Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6197037 Hair Mar 2001 B1
6200321 Orbay et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6200345 Morgan Mar 2001 B1
6224600 Protogirou May 2001 B1
6248109 Stofella Jun 2001 B1
6299613 Ogilvie et al. Oct 2001 B1
6305053 Galbreath Oct 2001 B1
6306140 Siddiqui Oct 2001 B1
6319284 Rushdy et al. Nov 2001 B1
6332885 Martella Dec 2001 B1
6336928 Guerin et al. Jan 2002 B1
6352560 Poeschmann et al. Mar 2002 B1
6383223 Baehler et al. May 2002 B1
6386877 Sutter May 2002 B1
6406234 Frigg Jun 2002 B2
6413260 Berrevoets et al. Jul 2002 B1
6419706 Graf Jul 2002 B1
6423097 Rauscher Jul 2002 B2
6428634 Besselink et al. Aug 2002 B1
6436099 Drewry et al. Aug 2002 B1
6451057 Chen et al. Sep 2002 B1
6454808 Masada Sep 2002 B1
6458134 Songer et al. Oct 2002 B1
6475242 Bramlet Nov 2002 B1
6508841 Martin et al. Jan 2003 B2
6517543 Berrevoets et al. Feb 2003 B1
6533788 Orbay Mar 2003 B1
6551321 Burkinshaw Apr 2003 B1
6551343 Törmälä et al. Apr 2003 B1
6575973 Shekalim Jun 2003 B1
6575976 Grafton Jun 2003 B2
6582453 Tran et al. Jun 2003 B1
6648890 Culbert et al. Nov 2003 B2
6679668 Martin et al. Jan 2004 B2
6682565 Krishnan Jan 2004 B1
6685706 Padget et al. Feb 2004 B2
6699247 Zucherman et al. Mar 2004 B2
6699292 Ogilvie et al. Mar 2004 B2
6706045 Lin et al. Mar 2004 B2
6767350 Lob Jul 2004 B1
6773437 Ogilvie et al. Aug 2004 B2
6811568 Minamikawa Nov 2004 B2
6869449 Ball et al. Mar 2005 B2
6875235 Ferree Apr 2005 B2
7037309 Weil May 2006 B2
7037324 Martinek May 2006 B2
7037342 Nilsson et al. May 2006 B2
7041106 Carver May 2006 B1
7044953 Capanni May 2006 B2
7112214 Peterson et al. Sep 2006 B2
7182787 Hassler et al. Feb 2007 B2
7192445 Ellingsen et al. Mar 2007 B2
7207994 Vlahos et al. Apr 2007 B2
7240677 Fox Jul 2007 B2
7261716 Strobel Aug 2007 B2
7291175 Gordon Nov 2007 B1
7569061 Colleran Aug 2009 B2
7585316 Trieu Sep 2009 B2
7588603 Leonard Sep 2009 B2
7695471 Cheung et al. Apr 2010 B2
7708759 Lubbers et al. May 2010 B2
7727235 Contiliano et al. Jun 2010 B2
7780701 Meridew et al. Aug 2010 B1
7780737 Bonnard et al. Aug 2010 B2
7785357 Guan et al. Aug 2010 B2
7837738 Reigstad et al. Nov 2010 B2
7842091 Johnstone et al. Nov 2010 B2
7887589 Glenn et al. Feb 2011 B2
7909880 Grant Mar 2011 B1
7918879 Yeung et al. Apr 2011 B2
7959681 Lavi Jun 2011 B2
7963995 Richelsoph Jun 2011 B2
7976565 Meridew Jul 2011 B1
7985246 Trieu Jul 2011 B2
8002811 Corradi et al. Aug 2011 B2
8057524 Meridew Nov 2011 B2
8100983 Schulte Jan 2012 B2
8118839 Taylor Feb 2012 B2
8118849 Wahl et al. Feb 2012 B2
8197509 Contiliano et al. Jun 2012 B2
8262712 Coilard-Lavirotte et al. Sep 2012 B2
8267939 Cipoletti et al. Sep 2012 B2
8337537 Pelo et al. Dec 2012 B2
8394097 Peyrot et al. Mar 2013 B2
8394132 Lewis et al. Mar 2013 B2
8414583 Prandi et al. Apr 2013 B2
8465525 Hawkins et al. Jun 2013 B2
8475456 Augoyard et al. Jul 2013 B2
8523944 Jimenez et al. Sep 2013 B2
8591545 Lunn et al. Nov 2013 B2
8608785 Reed et al. Dec 2013 B2
8616091 Anderson Dec 2013 B2
8636457 Connors Jan 2014 B2
8641769 Malandain Feb 2014 B2
8647390 Bellemere et al. Feb 2014 B2
8764842 Graham Jul 2014 B2
8840677 Kale et al. Sep 2014 B2
8888779 Senn Nov 2014 B2
D720072 Cheney et al. Dec 2014 S
8906060 Hart Dec 2014 B2
8986386 Oglaza et al. Mar 2015 B2
8998999 Lewis et al. Apr 2015 B2
9044287 Reed et al. Jun 2015 B2
9056014 McCormick et al. Jun 2015 B2
9125704 Reed et al. Sep 2015 B2
9138274 Biesinger Sep 2015 B1
9149268 Graul et al. Oct 2015 B2
20010025199 Rauscher Sep 2001 A1
20010028836 Kohori Oct 2001 A1
20010049529 Cachia et al. Dec 2001 A1
20020019636 Ogilvie et al. Feb 2002 A1
20020022887 Huene Feb 2002 A1
20020026194 Morrison et al. Feb 2002 A1
20020055785 Harris May 2002 A1
20020065561 Ogilvie et al. May 2002 A1
20020068939 Levy et al. Jun 2002 A1
20020072803 Saunders et al. Jun 2002 A1
20020082705 Bouman et al. Jun 2002 A1
20020111690 Hyde Aug 2002 A1
20020128713 Ferree Sep 2002 A1
20020165544 Perren et al. Nov 2002 A1
20020183846 Kuslich et al. Dec 2002 A1
20030032961 Pelo et al. Feb 2003 A1
20030040805 Minamikawa Feb 2003 A1
20030069645 Ball et al. Apr 2003 A1
20030130660 Levy et al. Jul 2003 A1
20030191422 Sossong Oct 2003 A1
20030233095 Urbanski et al. Dec 2003 A1
20040010315 Song Jan 2004 A1
20040093081 Nilsson et al. May 2004 A1
20040097941 Weiner et al. May 2004 A1
20040102853 Boumann et al. May 2004 A1
20040111117 Colleran et al. Jun 2004 A1
20040133204 Davies Jul 2004 A1
20040138756 Reeder Jul 2004 A1
20040220574 Pelo et al. Nov 2004 A1
20040220678 Chow et al. Nov 2004 A1
20040230193 Cheung et al. Nov 2004 A1
20040230194 Urbanski et al. Nov 2004 A1
20040230313 Saunders Nov 2004 A1
20040249461 Ferree Dec 2004 A1
20050113836 Lozier et al. May 2005 A1
20050119757 Hassler et al. Jun 2005 A1
20050123672 Justin et al. Jun 2005 A1
20050124443 Summers Jun 2005 A1
20050149031 Ciccone et al. Jul 2005 A1
20050177158 Doubler et al. Aug 2005 A1
20050187636 Graham Aug 2005 A1
20050251265 Calandruccio et al. Nov 2005 A1
20050261768 Trieu Nov 2005 A1
20050283159 Amara Dec 2005 A1
20060052725 Santilli Mar 2006 A1
20060052878 Schmieding Mar 2006 A1
20060074421 Bickley et al. Apr 2006 A1
20060074488 Abdou Apr 2006 A1
20060074492 Frey Apr 2006 A1
20060084998 Levy et al. Apr 2006 A1
20060100715 De Villiers May 2006 A1
20060129153 Klaue Jun 2006 A1
20060149258 Sousa Jul 2006 A1
20060173462 Kay et al. Aug 2006 A1
20060200151 Ducharme et al. Sep 2006 A1
20060229617 Meller et al. Oct 2006 A1
20060247787 Rydell et al. Nov 2006 A1
20070038303 Myerson et al. Feb 2007 A1
20070078518 Lavi Apr 2007 A1
20070106283 Garcia et al. May 2007 A1
20070123873 Czartoski et al. May 2007 A1
20070123993 Hassler et al. May 2007 A1
20070142920 Niemi Jun 2007 A1
20070177959 Chopp et al. Aug 2007 A1
20070185583 Branemark Aug 2007 A1
20070185584 Kaufmann et al. Aug 2007 A1
20070198018 Biedermann et al. Aug 2007 A1
20070213831 de Cubber Sep 2007 A1
20070239158 Trieu et al. Oct 2007 A1
20070293866 Stroeckel et al. Dec 2007 A1
20080039949 Meesenburg et al. Feb 2008 A1
20080051912 Hollawell Feb 2008 A1
20080086139 Bourke Apr 2008 A1
20080132894 Coilard-Lavirotte et al. Jun 2008 A1
20080132958 Pech et al. Jun 2008 A1
20080154385 Trail et al. Jun 2008 A1
20080161919 Melkent Jul 2008 A1
20080177262 Augoyard et al. Jul 2008 A1
20080177291 Jensen et al. Jul 2008 A1
20080177334 Stinnette Jul 2008 A1
20080195215 Morton Aug 2008 A1
20080195219 Wiley et al. Aug 2008 A1
20080221574 Cavallazzi Sep 2008 A1
20080221697 Graser Sep 2008 A1
20080221698 Berger Sep 2008 A1
20080255618 Fisher et al. Oct 2008 A1
20080269908 Warburton Oct 2008 A1
20080294204 Chirico et al. Nov 2008 A1
20090005782 Chirico et al. Jan 2009 A1
20090012564 Chirico et al. Jan 2009 A1
20090036893 Kartalian et al. Feb 2009 A1
20090149891 Lee et al. Jun 2009 A1
20090163918 Levy et al. Jun 2009 A1
20090187219 Pachtman et al. Jul 2009 A1
20090204158 Sweeney Aug 2009 A1
20090210016 Champagne et al. Aug 2009 A1
20090216282 Blake et al. Aug 2009 A1
20090254189 Scheker Oct 2009 A1
20090254190 Gannoe et al. Oct 2009 A1
20090259316 Ginn et al. Oct 2009 A1
20100010637 Pequignot Jan 2010 A1
20100016982 Solomons Jan 2010 A1
20100023012 Voor Jan 2010 A1
20100030221 Christian et al. Feb 2010 A1
20100049244 Cohen et al. Feb 2010 A1
20100057214 Graham et al. Mar 2010 A1
20100061825 Liu Mar 2010 A1
20100069913 Chirico Mar 2010 A1
20100069970 Lewis et al. Mar 2010 A1
20100121390 Kleinman May 2010 A1
20100125274 Greenhalgh et al. May 2010 A1
20100131014 Peyrot et al. May 2010 A1
20100131072 Schulte May 2010 A1
20100161068 Lindner et al. Jun 2010 A1
20100185295 Emmanuel Jul 2010 A1
20100217325 Hochschuler et al. Aug 2010 A1
20100249942 Goswami et al. Sep 2010 A1
20100256639 Tyber Oct 2010 A1
20100256770 Hakansson et al. Oct 2010 A1
20100262254 Lawrence et al. Oct 2010 A1
20100274293 Terrill et al. Oct 2010 A1
20100286692 Greenhalgh et al. Nov 2010 A1
20100292799 Hansell et al. Nov 2010 A1
20100324556 Tyber Dec 2010 A1
20100331893 Geist et al. Dec 2010 A1
20110004255 Weiner Jan 2011 A1
20110004317 Hacking et al. Jan 2011 A1
20110066190 Schaller et al. Mar 2011 A1
20110082507 Klaue Apr 2011 A1
20110082508 Reed Apr 2011 A1
20110093017 Prasad et al. Apr 2011 A1
20110093075 Duplessis et al. Apr 2011 A1
20110093085 Morton Apr 2011 A1
20110118739 Tyber May 2011 A1
20110144644 Prandi Jun 2011 A1
20110144766 Kale et al. Jun 2011 A1
20110208252 Erhart Aug 2011 A1
20110257652 Roman Oct 2011 A1
20110301652 Reed Dec 2011 A1
20110301653 Reed Dec 2011 A1
20110306975 Kaikkonen et al. Dec 2011 A1
20110319946 Levy et al. Dec 2011 A1
20120016428 White et al. Jan 2012 A1
20120065692 Champagne et al. Mar 2012 A1
20120065738 Schulman Mar 2012 A1
20120089197 Anderson Apr 2012 A1
20120136448 Seifert et al. May 2012 A1
20120209337 Weinstein Aug 2012 A1
20120259419 Brown et al. Oct 2012 A1
20120271362 Martineau et al. Oct 2012 A1
20120323241 McClellan et al. Dec 2012 A1
20130030475 Weiner et al. Jan 2013 A1
20130053975 Reed et al. Feb 2013 A1
20130060295 Reed et al. Mar 2013 A1
20130066383 Anderson Mar 2013 A1
20130066435 Averous Mar 2013 A1
20130079776 Zwirkoski Mar 2013 A1
20130090655 Tontz Apr 2013 A1
20130096634 Suh Apr 2013 A1
20130123862 Anderson May 2013 A1
20130131822 Lewis May 2013 A1
20130150965 Taylor Jun 2013 A1
20130190761 Prandi et al. Jul 2013 A1
20130211451 Wales et al. Aug 2013 A1
20130226191 Thoren Aug 2013 A1
20130253597 Augoyard et al. Sep 2013 A1
20130274814 Weiner et al. Oct 2013 A1
20130317559 Leavitt Nov 2013 A1
20130325138 Graham Dec 2013 A1
20140018930 Oster Jan 2014 A1
20140025125 Sack et al. Jan 2014 A1
20140052196 McGinley Feb 2014 A1
20140107713 Pech et al. Apr 2014 A1
20140135768 Roman May 2014 A1
20140142715 McCormick May 2014 A1
20140180428 McCormick Jun 2014 A1
20140188179 McCormick Jul 2014 A1
20140188237 McCormick et al. Jul 2014 A1
20140188239 Cummings Jul 2014 A1
20140257289 Kecman et al. Sep 2014 A1
20140276825 Brown et al. Sep 2014 A1
20140277185 Boileau et al. Sep 2014 A1
20140277186 Granberry et al. Sep 2014 A1
20150012098 Eastlack et al. Jan 2015 A1
20150018954 Loebl et al. Jan 2015 A1
20150073413 Palmer Mar 2015 A1
20150088136 Kotuljac et al. Mar 2015 A1
20150088266 Sander et al. Mar 2015 A1
20150094778 McCormick et al. Apr 2015 A1
20150112342 Penzimer Apr 2015 A1
20150141994 Cheney et al. May 2015 A1
20150142066 Shemwell May 2015 A1
20150164563 Lewis et al. Jun 2015 A1
20150223848 McCormick et al. Aug 2015 A1
20150223849 McCormick Aug 2015 A1
20150342655 Reed et al. Dec 2015 A1
Foreign Referenced Citations (75)
Number Date Country
201085677 Jul 2008 CN
0127994 Dec 1984 EP
0340159 Nov 1989 EP
0409364 Jan 1991 EP
0545830 Jun 1993 EP
0551846 Jul 1993 EP
0611557 Aug 1994 EP
0738502 Oct 1996 EP
880950 Dec 1998 EP
1300122 Apr 2003 EP
1825826 Aug 2007 EP
1870050 Dec 2007 EP
1708653 Sep 2009 EP
1923012 Jun 2010 EP
1868536 Nov 2010 EP
2275055 May 2012 EP
2221025 Dec 2012 EP
2221026 Mar 2013 EP
2564799 Mar 2013 EP
2774556 Sep 2014 EP
736058 Nov 1932 FR
1036978 Sep 1953 FR
2603794 Mar 1988 FR
2605878 May 1988 FR
2628312 Sep 1989 FR
2645735 Oct 1990 FR
2651119 Mar 1991 FR
2663838 Jan 1993 FR
2694696 Feb 1994 FR
2725126 Apr 1996 FR
2743490 Jul 1997 FR
2754702 Apr 1998 FR
2783702 Mar 2000 FR
2787313 Jun 2000 FR
2794019 Dec 2000 FR
2801189 May 2001 FR
2846545 May 2004 FR
2728779 Jul 2005 FR
2884406 Oct 2006 FR
2927529 Aug 2009 FR
2935601 Mar 2010 FR
140983 Apr 1920 GB
2119655 Nov 1983 GB
2227540 Jan 1990 GB
2336415 Oct 1999 GB
2430625 Apr 2007 GB
S53-128181 Nov 1978 JP
60145133 Jul 1985 JP
H07-500520 Jan 1995 JP
07303662 Nov 1995 JP
2004535249 Nov 2004 JP
2007530194 Nov 2007 JP
2008-188411 Aug 2008 JP
2009-160399 Jul 2009 JP
2010-046481 Mar 2010 JP
2011-502584 Jan 2011 JP
2011-525229 Sep 2011 JP
1152582 Apr 1985 SU
WO 9217122 Oct 1992 WO
WO 9641596 Dec 1996 WO
WO 9817189 Apr 1998 WO
WO 9847449 Oct 1998 WO
WO 9921515 May 1999 WO
WO 0180751 Nov 2001 WO
WO 0234107 May 2002 WO
WO 2005063149 Jul 2005 WO
WO2005094706 Oct 2005 WO
WO 2005104961 Nov 2005 WO
WO 2006103598 Oct 2006 WO
WO2006109004 Oct 2006 WO
WO2007135322 Nov 2007 WO
WO 2009155577 Dec 2009 WO
WO 2013096746 Jun 2013 WO
WO 2013131974 Sep 2013 WO
WO 2014165123 Oct 2014 WO
Non-Patent Literature Citations (22)
Entry
U.S. Appl. No. 13/086,136—Non-Final Office Action dated Feb. 4, 2013, 6 pages.
U.S. Appl. No. 13/086,136—Final Office Action dated Sep. 18, 2013, 9 pages.
U.S. Appl. No. 13/086,136—Non-Final Office Action dated Dec. 30, 2013, 11 pages.
U.S. Appl. No. 13/086,136—Final Office Action dated May 29, 2014, 14 pages.
U.S. Appl. No. 13/086,136—Advisory Action dated Oct. 10, 2014, 4 pages.
U.S. Appl. No. 13/660,522—Non-Final Office Action dated Dec. 24, 2013, 9 pages.
U.S. Appl. No. 13/660,522—Final Office Action dated May 30, 2014, 13 pages.
U.S. Appl. No. 13/660,495—Non-final Office Action dated Dec. 26, 2013, 8 pages.
U.S. Appl. No. 13/660,495—Final Office Action dated May 29, 2014, 12 pages.
U.S. Appl. No. 13/660,495—Advisory Action dated Oct. 10, 2014, 4 pages.
Brochure MKT 016 A: iFuse HT Hammertoe Correction Implant, OrthoPro LLC, 2 pages, undated.
Brochure p/n 030-1788 Rev A: ExtremiFuse Hammertoe Fixation System, OsteoMED Small Bone Orthopedics, 6 pages, undated.
Brochure 900-01-008 Rev C: Hammer Toe Implant System Instructions for Use, Trilliant Surgical Ltd, 2 pages, undated.
Bensmann, et al., “Nickel-titanium Osteosynthesis Clips,” Reprint from Medical Focus, 1983.
Besselink, Sachdeva, “Applications of Shape Memory Effects,” Memory Metal Holland, Memory Medical Systems, Publication Date Unknown.
Dai, K.R., et al., “Treatment of Intra-Articular Fractures with Shape Memory Compression Staples,” Injury, (1993) 24, (IO), 651-655.
Haasters, Dr. J., et al., “The Use of N—Ti As An Implant Material in Orthopedics”, pp. 426-444.
Kuo, M.D., et al., “The Use of Nickel-Titanium Alloy in Orthopedic Surgery in China,” Orthopedics, Jan. 1989, vol. 12/No. 1.
Lu, M.D., Shibi, “Medical Applications of Ni—Ti Alloys in China,” pp. 445-451.
Ricart, “The Use of a Memory Shape Staple in Cervical Anterior Fusion,” Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies, Asilomar Conference Center, Pacific Grove, CA, USA, Mar. 2-6, 1997.
Ricart, “The Use of a Memory-Shaple Staple in Cervical Anterior Fusion,” in Shape Memory Implants, Springer-Verlag Berlin Heidelberg, 2000.
Tang, Dai, Chen, “Application of a Ni—Ti Staple in the Metatarsal Osteotomy,” Bio-Medical Materials and Engineering 6, (1996), 307-312, IOS Press.
Related Publications (1)
Number Date Country
20150142066 A1 May 2015 US